1. Home
  2. MCHX vs UNCY Comparison

MCHX vs UNCY Comparison

Compare MCHX & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCHX
  • UNCY
  • Stock Information
  • Founded
  • MCHX 2003
  • UNCY 2016
  • Country
  • MCHX United States
  • UNCY United States
  • Employees
  • MCHX N/A
  • UNCY N/A
  • Industry
  • MCHX Business Services
  • UNCY Biotechnology: Pharmaceutical Preparations
  • Sector
  • MCHX Consumer Discretionary
  • UNCY Health Care
  • Exchange
  • MCHX Nasdaq
  • UNCY Nasdaq
  • Market Cap
  • MCHX 84.3M
  • UNCY 74.2M
  • IPO Year
  • MCHX 2004
  • UNCY 2021
  • Fundamental
  • Price
  • MCHX $1.96
  • UNCY $4.74
  • Analyst Decision
  • MCHX
  • UNCY Strong Buy
  • Analyst Count
  • MCHX 0
  • UNCY 5
  • Target Price
  • MCHX N/A
  • UNCY $55.20
  • AVG Volume (30 Days)
  • MCHX 24.6K
  • UNCY 510.5K
  • Earning Date
  • MCHX 10-30-2025
  • UNCY 11-12-2025
  • Dividend Yield
  • MCHX N/A
  • UNCY N/A
  • EPS Growth
  • MCHX N/A
  • UNCY N/A
  • EPS
  • MCHX N/A
  • UNCY N/A
  • Revenue
  • MCHX $47,534,000.00
  • UNCY N/A
  • Revenue This Year
  • MCHX N/A
  • UNCY N/A
  • Revenue Next Year
  • MCHX $7.56
  • UNCY $4,481.14
  • P/E Ratio
  • MCHX N/A
  • UNCY N/A
  • Revenue Growth
  • MCHX N/A
  • UNCY N/A
  • 52 Week Low
  • MCHX $1.26
  • UNCY $3.40
  • 52 Week High
  • MCHX $2.40
  • UNCY $11.00
  • Technical
  • Relative Strength Index (RSI)
  • MCHX 50.62
  • UNCY 63.48
  • Support Level
  • MCHX $1.65
  • UNCY $4.51
  • Resistance Level
  • MCHX $1.98
  • UNCY $4.84
  • Average True Range (ATR)
  • MCHX 0.09
  • UNCY 0.23
  • MACD
  • MCHX 0.00
  • UNCY 0.09
  • Stochastic Oscillator
  • MCHX 72.57
  • UNCY 87.95

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: